Moderna doses the first participant in a phase III study evaluating its mRNA norovirus vaccine candidate, mRNA-1403, in the ...
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / (NASDAQ:MRNA) today announced that the first participant in the U.S. has ...
Additionally, the company is working on a trivalent norovirus vaccine candidate, mRNA-1403, and plans to initiate a pivotal phase 3 trial imminently. Oncology Therapeutics: Moderna’s oncology ...
The seeds of Spanish filmmaker Pedro Almodóvar’s later cinematic work are scattered throughout the pages of “The Last Dream,” ...
A judge has rejected a request to throw out the conviction of a movie armorer in the fatal shooting of a cinematographer by ...